Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 207-079-2 | CAS number: 431-89-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Short description of key information on bioaccumulation potential result:
The available data indicate that 1,1,1,2,3,3,3-heptafluoropropane is rapidly adsorbed upon inhalation. In rats, it is biotransformed at very low rates to hexafluoroacetone trihydrate (amount in the urine not quantifiable due to very low concentration), following 6 hours inhalation exposure. A study with human volunteers indicated that the substance is rapidly cleared at each exposure concentrations, with the substance concentration in blood below quantifiable limit (0.010 μg/m) at 24 h post-exposure.
Key value for chemical safety assessment
Additional information
Biotransformation of 1,1,1,2,3,3,3 -heptafluoropropane (HFC 277ea) was investigated in vivo in rats, by exposing 3 male rats for 6 hours to a sinlge dose of 5000 ppm of the test substance. After the exposure, the urine was collected for 24 hr and analyzed for fluoride content using NMR technique (Koster et al., 1996).
19F-NMR identified hexafluoroacetone trihydrate in the urine of exposed rats. No significant increase of inorganic fluoride was observed in urinary excretion compared to untreated rats (0-48 hours after the end of the exposure). Because of the very low concentrations of hexafluoroacetone trihydrate present in the collected urine samples, the amount of this metabolite could not be quantified.
Pharmacokinetics of 1,1,1,2,3,3,3 -heptafluoropropane was also investigated in the study with 8 male and female human volunteers, using exposure concentrations 0, 1000, 2000, 4000 and 8000 ppm. Exposure was for 1 h on eight separate occasions, separated generally by 7 days, two air exposures, two exposures to dichlorodifluoromethane (at 1000 and 4000 ppm), and four exposures (at 1000, 2000, 4000 and 8000 ppm) to 1,1,1,2,3,3,3 -heptafluoropropane (Emmen et al., 1999).
The blood concentration-time profile shows that 1,1,1,2,3,3,3-heptafluoropropane was rapidly absorbed at each exposure concentration in both males and females, with a rapid increase and either maximum or near maximum concentration in blood observed after 15 min at each exposure concentrations.
Blood concentrations appeared to be at steady state, with maximum blood concentrations generally measured (52% of the cases) prior to the final sample taken during exposure. The substance was rapidly cleared at each exposure concentration in both males and females. Elimination was predominantly (>83%) biphasic at each exposure level, gender dependent and exposure concentration independent. In the remainder of the population, a single elimination phase was observed.Following the final exposure at 24-h, blood samples was analyzed for 1,1,1,2,3,3,3-heptafluoropropane. All samples were below the limit of quantification (0.010 μg/ml). Also no metabolites were identified.
The results appear to indicate that the substance is rapidly absorbed upon inhalation, but is also rapidly eliminated, with no traces of substances detected in blood 24 hours after exposure. Available data also appear to suggest that the majority of the substance is excreted unmetabolized. Hexafluoroacetone trihydrate was detected as an only metabolite in the urine of exposed rats; however, its concentration was too low to be quantified.
As the substance is a gas, information on dermal absorption is considered to be irrelevant.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
Questo sito web si avvale di cookie affinché possiate usufruire della migliore esperienza sui nostri siti web.